The expression of Ki-S1 and BCL-2 and the response to primary tamoxifen therapy in elderly patients with breast cancer.

This publication has 21 references indexed in Scilit:

• BCL‐2 expression in adult and embryonic non‐haematopoietic tissues
  The Journal of Pathology, 1993
• Tumour oestrogen receptor content allows selection of elderly patients with breast cancer for conservative tamoxifen treatment
  British Journal of Surgery, 1992
• BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.
  Proceedings of the National Academy of Sciences, 1991
• Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections.
  Journal of Histochemistry & Cytochemistry, 1991
• Long-term follow-up of elderly patients with locoregional breast cancer treated with tamoxifen only
  British Journal of Surgery, 1991
• Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
  Nature, 1990
• A pilot trial to evaluate the acute toxicity and feasibility of tamoxifen for prevention of breast cancer
  British Journal of Cancer, 1989
• A HUMAN TUMOUR MODEL
  The Lancet, 1986
• The pharmacology and clinical uses of tamoxifen
  Pharmacology & Therapeutics, 1984
• Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.
  Journal of Histochemistry & Cytochemistry, 1981